关注
Larissa D Cunha
Larissa D Cunha
Professor Visitante, FMRP-USP
在 usp.br 的电子邮件经过验证
标题
引用次数
引用次数
年份
SARS-CoV-2–triggered neutrophil extracellular traps mediate COVID-19 pathology
FP Veras, MC Pontelli, CM Silva, JE Toller-Kawahisa, M de Lima, ...
Journal of Experimental Medicine 217 (12), e20201129, 2020
8622020
RETRACTED ARTICLE: Molecular characterization of LC3-associated phagocytosis reveals distinct roles for Rubicon, NOX2 and autophagy proteins
J Martinez, RKS Malireddi, Q Lu, LD Cunha, S Pelletier, S Gingras, ...
Nature cell biology 17 (7), 893-906, 2015
8252015
Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients
TS Rodrigues, KSG de Sá, AY Ishimoto, A Becerra, S Oliveira, L Almeida, ...
Journal of Experimental Medicine 218 (3), 2021
7512021
Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease
H Chu, A Khosravi, IP Kusumawardhani, AHK Kwon, AC Vasconcelos, ...
Science 352 (6289), 1116-1120, 2016
6012016
Inflammasome-derived IL-1β production induces nitric oxide–mediated resistance to Leishmania
DS Lima-Junior, DL Costa, V Carregaro, LD Cunha, ALN Silva, ...
Nature medicine 19 (7), 909-915, 2013
4002013
LC3-associated phagocytosis in myeloid cells promotes tumor immune tolerance
LD Cunha, M Yang, R Carter, C Guy, L Harris, JC Crawford, G Quarato, ...
Cell 175 (2), 429-441. e16, 2018
2842018
NLRP3 inflammasome–mediated neutrophil recruitment and hypernociception depend on leukotriene B4 in a murine model of gout
FA Amaral, VV Costa, LD Tavares, D Sachs, FM Coelho, CT Fagundes, ...
Arthritis & Rheumatism 64 (2), 474-484, 2012
2562012
LC3-associated phagocytosis and inflammation
BL Heckmann, E Boada-Romero, LD Cunha, J Magne, DR Green
Journal of molecular biology 429 (23), 3561-3576, 2017
2402017
Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial
MI Lopes, LP Bonjorno, MC Giannini, NB Amaral, PI Menezes, SM Dib, ...
RMD open 7 (1), e001455, 2021
2292021
Cutting edge: nucleotide-binding oligomerization domain 1-dependent responses account for murine resistance against Trypanosoma cruzi infection
GK Silva, FRS Gutierrez, PMM Guedes, CV Horta, LD Cunha, TWP Mineo, ...
The journal of immunology 184 (3), 1148-1152, 2010
1492010
Inhibition of caspase-1 or gasdermin-D enable caspase-8 activation in the Naip5/NLRC4/ASC inflammasome
DPA Mascarenhas, DM Cerqueira, MSF Pereira, FVS Castanheira, ...
PLoS pathogens 13 (8), e1006502, 2017
1342017
Critical role of ASC inflammasomes and bacterial type IV secretion system in caspase-1 activation and host innate resistance to Brucella abortus infection
MTR Gomes, PC Campos, FS Oliveira, PP Corsetti, KR Bortoluci, ...
The Journal of Immunology 190 (7), 3629-3638, 2013
1252013
Inhibition of inflammasome activation by Coxiella burnetii type IV secretion system effector IcaA
LD Cunha, JM Ribeiro, TD Fernandes, LM Massis, CA Khoo, JH Moffatt, ...
Nature communications 6 (1), 10205, 2015
992015
Subversion of inflammasome activation and pyroptosis by pathogenic bacteria
LD Cunha, DS Zamboni
Frontiers in cellular and infection microbiology 3, 76, 2013
972013
Caspase-1 but not caspase-11 is required for NLRC4-mediated pyroptosis and restriction of infection by flagellated Legionella species in mouse macrophages and in vivo
DM Cerqueira, MSF Pereira, ALN Silva, LD Cunha, DS Zamboni
The Journal of Immunology 195 (5), 2303-2311, 2015
862015
AIM2 engages active but unprocessed caspase-1 to induce noncanonical activation of the NLRP3 inflammasome
LD Cunha, ALN Silva, JM Ribeiro, DPA Mascarenhas, GFS Quirino, ...
Cell reports 20 (4), 794-805, 2017
762017
A novel pathway for inducible nitric-oxide synthase activation through inflammasomes
CL Buzzo, JC Campopiano, LM Massis, SL Lage, AA Cassado, ...
Journal of biological chemistry 285 (42), 32087-32095, 2010
622010
Gasdermin-D activation by SARS-CoV-2 triggers NET and mediate COVID-19 immunopathology
CMS Silva, CWS Wanderley, FP Veras, AV Gonçalves, MHF Lima, ...
Critical Care 26 (1), 206, 2022
442022
Beneficial effects of colchicine for moderate to severe COVID-19: an interim analysis of a randomized, double-blinded, placebo controlled clinical trial
MIF Lopes, LP Bonjorno, MC Giannini, NB Amaral, MN Benatti, UC Rezek, ...
MedRxiv, 2020.08. 06.20169573, 2020
422020
Efferocytosis of SARS-CoV-2-infected dying cells impairs macrophage anti-inflammatory functions and clearance of apoptotic cells
ACG Salina, D Dos-Santos, TS Rodrigues, M Fortes-Rocha, ...
Elife 11, e74443, 2022
352022
系统目前无法执行此操作,请稍后再试。
文章 1–20